138 related articles for article (PubMed ID: 2257212)
21. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
22. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
23. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
25. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
[TBL] [Abstract][Full Text] [Related]
26. HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck.
Houck JR; Sexton FM; Zajdel G
Arch Otolaryngol Head Neck Surg; 1990 Oct; 116(10):1181-5. PubMed ID: 2206503
[TBL] [Abstract][Full Text] [Related]
27. [Several blood group antigens expressions in laryngeal cancer tissue and their clinical significance].
Ji W; Fei S; Pan Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(6):330-2. PubMed ID: 7742021
[TBL] [Abstract][Full Text] [Related]
28. Morphological observations of immunobiology of laryngeal cancer. Evaluation of the defensive activity of immunocompetent cells present in tumour stroma.
Sala O; Ferlito A
Acta Otolaryngol; 1976; 81(3-4):353-63. PubMed ID: 1266621
[TBL] [Abstract][Full Text] [Related]
29. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.
Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL
Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485
[TBL] [Abstract][Full Text] [Related]
30. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
31. Tumor infiltrating lymphocytes in HLA+ and HLA- laryngeal cancer--quantitative approach.
Dworacki G; Kruk-Zagajewska A; Jezewska E; Sikora J; Zeromski J
Arch Immunol Ther Exp (Warsz); 1999; 47(3):161-8. PubMed ID: 10470443
[TBL] [Abstract][Full Text] [Related]
32. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
33. MHC antigen expression in human oral squamous carcinoma cell lines.
Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
[TBL] [Abstract][Full Text] [Related]
34. [Histopathological malignancy and prognosis of laryngeal cancer].
Solano J; Esteban F; Delgado M; González M; Zaragoza L
Acta Otorrinolaringol Esp; 1997; 48(5):375-82. PubMed ID: 9376158
[TBL] [Abstract][Full Text] [Related]
35. Expression of dendritic cell phenotypic antigens in cervical lymph nodes of patients with hypopharyngeal and laryngeal carcinoma.
Li X; Takahashi Y; Sakamoto K; Nakashima T
J Laryngol Otol Suppl; 2009; (31):5-10. PubMed ID: 19460197
[TBL] [Abstract][Full Text] [Related]
36. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
37. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
38. [Immunohistochemical studies of advanced laryngeal and hypopharyngeal carcinomas 3 days after administration of monoclonal antibody against epidermal growth factor receptor].
Haas I; Koldovsky P; Bier H
Laryngorhinootologie; 1994 Dec; 73(12):626-30. PubMed ID: 7840824
[TBL] [Abstract][Full Text] [Related]
39. Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix.
Honma S; Tsukada S; Honda S; Nakamura M; Takakuwa K; Maruhashi T; Kodama S; Kanazawa K; Takahashi T; Tanaka K
Int J Cancer; 1994 Jun; 57(5):650-5. PubMed ID: 8194872
[TBL] [Abstract][Full Text] [Related]
40. HLA-DR expression is a significant prognostic factor in laryngeal cancer. A morphometric study.
Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
APMIS; 1999 Apr; 107(4):383-8. PubMed ID: 10230691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
